W. Brooks Gentry

OverviewAI-generated summary

W. Brooks Gentry's research focuses on developing therapeutic interventions for methamphetamine use. His work has involved the creation and evaluation of monoclonal antibodies designed to neutralize the effects of methamphetamine. Recent publications detail the identification of candidate antibodies and their efficacy in preclinical studies, including assessments of cross-reactivity and impact on locomotor activity in animal models.

Gentry's scholarship metrics include a total of 62 publications and 2,564 citations, with an h-index of 28. He is recognized as a highly cited researcher. His collaborations include work with Michael D. Berquist and Melinda G. Gunnell at the University of Arkansas for Medical Sciences, with whom he shares multiple publications.

Metrics

• h-index: 28
• Publications: 62
• Citations: 2,572